PD-1/PD-L1 Blockade: A New Promising Therapy for the Treatment of Pancreatic Cancer?
Journal Title: Pancreas – Open Journal - Year 2018, Vol 2, Issue 1
Abstract
Programmed cell death protein 1 (PD-1), a member of the CD28 family, is an immune-checkpoint receptor expressed on a variety of immune cells, such as T-cells, monocytes, B-cells, dendritic cells, and tumor-infiltrating lymphocytes (TILs).1 PD-1 major role is to limit the activity of T-cells in peripheral tissues at the time of an inflammatory response to constrain autoimmunity and tissue damage.1,2 Engagement of PD-1 by one of its two known ligands (PD-L1 and PD-L2) inhibits kinases involved in immune cell activation.2 Interestingly, PD-1 has an opposite function in Treg lymphocytes.3
Authors and Affiliations
Nicoletta Gagliano
Keywords
Related Articles
- EP ID EP556740
- DOI 10.17140/POJ-2-e007
- Views 194
- Downloads 0
Recurrent Acute Pancreatitis: Dangerous Etiology?
Acute pancreatitis (AP) is a disorder clinically characterized by upper abdominal pain and elevated levels of pancreatic enzymes in the blood.1 After an initial evaluation, up to 10-30% of patients with AP are diagnosed...
Ultrasound Ablation in Advanced Pancreatic Cancer Patients – What should be the Next Step?
In the last decades the treatment for many diseases has changed dramatically. Open surgery procedures with high morbidity and complication rates, suboptimal clinical results based on large impairment for the patients wer...
Pancreas: Do All Roads Lead to Mitochondria?
Over several millions of years of evolution, mitochondria have transformed into specialized organelles. Today, they cannot live outside the cell nor can the host cell live without them, resulting in a symbiotic relations...
Epigenetic Alterations in Pancreatic Cancer
Pancreatic cancer is the fourth leading cause of cancer death and is predicted to be the second leading cause in a decade in the US. Despite more than 50 years of research and therapeutic development, pancreatic cancer s...
ADAM10 Proteases and Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is the 4th leading cause of cancer-related deaths in the United States and is expected to rise to the second rank by 2020.1 The survival rate of PDAC is estimated at less than 5% a...